How to Help Your Patients Save Money on Qsymia: A Provider's Guide to Savings Programs

Cost is one of the most common reasons patients abandon Qsymia therapy. At retail prices of $200–$282 per month without a discount program, many patients see the number at the pharmacy counter and walk away—particularly those without commercial insurance or with high-deductible plans. As a prescriber, you can dramatically improve treatment persistence by briefing patients on savings options before they go to the pharmacy.

This guide consolidates every available Qsymia savings mechanism with clinical context to help you advise patients effectively.

Understanding Qsymia's Cost Landscape

Before discussing savings options, it helps to understand the cost distribution across your patient population:

Commercially insured (plan covers Qsymia): Most plans require prior authorization. With coverage, copays are typically $20–$60/month. The Vivus savings card can reduce the copay further by $65 (after the patient covers the first $70).

Commercially insured (Qsymia not covered): Patient pays full cash price. The savings card, GoodRx exclusive, or home delivery program can bring this to $63–$149/month.

Uninsured / self-pay: GoodRx ($149/month), SingleCare (~$63/month), or Qsymia Engage home delivery ($89/month) are the best options. The manufacturer savings card provides $75 off per fill.

Medicare patients: Most Medicare Part D plans do not cover weight-loss medications. Some Medicare Advantage plans offer coverage. For most Medicare patients, cash-pay programs (GoodRx, Qsymia Engage) or switching to a generic (available since May 2025) are the primary options.

Medicaid patients: Approximately one-third of Medicaid plans and ACA marketplace plans cover Qsymia. State-level formularies vary significantly. If Qsymia is not covered, discuss generic phentermine/topiramate ER or consider naltrexone/bupropion ER (Contrave generic, often more broadly covered).

Program 1: Vivus Manufacturer Savings Card

The Qsymia Retail Pharmacy Savings Card, offered by Vivus, is available at no cost to patients via qsymia.com/patient/multiple-ways-to-save. Key clinical points:

For cash-pay patients: $75 off a 28–30 day supply (up to 100 fills); $70 off 3.75/23 mg starter dose (14–15 day supply, up to 10 fills)

For insured patients with coverage: $65 off (after patient covers first $70 of copay), up to 100 fills

Available at REMS-certified retail pharmacies; not applicable at home delivery

Caveat: Some states prohibit use of manufacturer coupons on Schedule IV controlled substances. Advise patients to confirm with their pharmacist.

Consider including the savings card URL in your after-visit summary or prescription instructions. Phone: 1-855-264-9634.

Program 2: GoodRx Exclusive Pricing ($149/Month)

Vivus has a partnership with GoodRx offering brand-name Qsymia at $149 per month at over 70,000 retail pharmacy locations nationwide. For patients who are cash-paying or whose insurance doesn't cover Qsymia, this is one of the easiest discounts to use—free GoodRx coupon, present at any REMS-certified participating pharmacy. Recommend patients download the GoodRx app or visit GoodRx.com.

Program 3: Qsymia Engage Home Delivery ($70–$89/Month)

The Qsymia Engage home delivery program provides the lowest cost for brand-name Qsymia and simultaneously solves the pharmacy access problem:

30-day supply: $89 (includes 6-week new patient packs and titration packs)

90-day supply: $210 ($70/month); free standard shipping on 90-day orders

Cash only—no insurance claims processed

Prescription must be for brand-name Qsymia and submitted directly to LifeLine Specialty Pharmacy

Not available in Puerto Rico, Guam, or U.S. Virgin Islands

This program is particularly useful for rural patients, those in areas with few certified pharmacies, and those who qualify for prior authorization but still face high out-of-pocket costs. Prescribers: have your staff note in the chart which savings program the patient is using so you can troubleshoot any refill issues.

Program 4: SingleCare and Other Discount Platforms

SingleCare offers some of the lowest documented prices for Qsymia—as low as approximately $63.35 per month for 30 capsules of the 7.5/46 mg dose at participating pharmacies. Prices vary by location and dose. Advise patients to compare GoodRx, SingleCare, and RxSaver prices at the specific REMS-certified pharmacy they plan to use.

Program 5: Generic Phentermine/Topiramate ER

The first generic version of phentermine/topiramate ER was released in May 2025. Generics are subject to the same REMS requirements but may be available at lower prices and at more certified pharmacy locations. For cost-sensitive patients, prescribing the generic (rather than brand-name Qsymia) may expand their access to a wider range of certified pharmacies.

When to Consider Switching to a Less Expensive Alternative

If a patient cannot access Qsymia at a manageable cost through any of the above programs, consider:

Generic phentermine + generic topiramate (separate prescriptions): $15–$50/month combined, no REMS required, avoids all distribution complexity

Generic naltrexone/bupropion ER (Contrave generic): $50–$150/month, not controlled, no REMS, broadly covered by more insurance plans

Workflow Integration: Savings Brief at Time of Prescribing

We recommend training your MAs and care coordinators to provide every Qsymia patient with a brief savings summary at the time of prescribing. A simple printed handout listing the savings card URL, GoodRx price, and Qsymia Engage information can prevent abandonment. Consider adding medfinder.com/providers to your patient education materials so patients can also find their nearest REMS-certified pharmacy.

For guidance on helping patients find a certified pharmacy for Qsymia, see our provider guide to finding Qsymia in stock.